Regression of left ventricular hypertrophy after tafamidis therapy in a patient with transthyretin amyloidosis variant

秀介八木, 政隆佐田, Muneyuki Kadota, Hiromu Yamazaki(Tokushima University), 賢也楠瀬, Tetsuzo Wakatsuki, Yusuke Osaki, 武添木, Rie Ueno, 浩司山口, 大受福田, 知也原, 博胤山田, 孝之伊勢, 良仁西條, Tomomi Matsuura(Keio University), 豊川端, Munkhtsetseg Tserensonom(Tokushima University)

Institutional Repositories DataBase (IRDB)

August 1, 2022

Cited by 0

Related Papers

Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes

|Cell stem cell|2012|1.1k

Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells

|Cell Metabolism|2016|252

Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway

|Nature Communications|2014|250

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus

|Diabetology & Metabolic Syndrome|2017|187

A defect of LigD (human Lig4 homolog) for nonhomologous end joining significantly improves efficiency of gene-targeting in Aspergillus oryzae

|Fungal Genetics and Biology|2008|176